- Home
- ARQT vs HLIO Comparison
ARQT vs HLIO Comparison
Compare ARQT & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- HLIO
- Stock Information
- Founded
- ARQT 2016
- HLIO 1970
- Country
- ARQT United States
- HLIO United States
- Employees
- ARQT N/A
- HLIO N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- HLIO Metal Fabrications
- Sector
- ARQT Health Care
- HLIO Industrials
- Exchange
- ARQT Nasdaq
- HLIO Nasdaq
- Market Cap
- ARQT 1.7B
- HLIO 1.8B
- IPO Year
- ARQT 2020
- HLIO N/A
- Fundamental
- Price
- ARQT $15.99
- HLIO $54.23
- Analyst Decision
- ARQT Strong Buy
- HLIO Strong Buy
- Analyst Count
- ARQT 7
- HLIO 4
- Target Price
- ARQT $19.00
- HLIO $44.25
- AVG Volume (30 Days)
- ARQT 1.8M
- HLIO 424.5K
- Earning Date
- ARQT 08-06-2025
- HLIO 08-04-2025
- Dividend Yield
- ARQT N/A
- HLIO 0.69%
- EPS Growth
- ARQT N/A
- HLIO 17.55
- EPS
- ARQT N/A
- HLIO 1.05
- Revenue
- ARQT $263,464,999.00
- HLIO $782,000,000.00
- Revenue This Year
- ARQT $61.83
- HLIO N/A
- Revenue Next Year
- ARQT $36.55
- HLIO $4.75
- P/E Ratio
- ARQT N/A
- HLIO $51.67
- Revenue Growth
- ARQT 99.50
- HLIO N/A
- 52 Week Low
- ARQT $8.03
- HLIO $24.76
- 52 Week High
- ARQT $17.75
- HLIO $57.29
- Technical
- Relative Strength Index (RSI)
- ARQT 56.88
- HLIO 76.80
- Support Level
- ARQT $15.43
- HLIO $50.72
- Resistance Level
- ARQT $17.29
- HLIO $53.53
- Average True Range (ATR)
- ARQT 0.97
- HLIO 1.82
- MACD
- ARQT 0.06
- HLIO 0.22
- Stochastic Oscillator
- ARQT 63.70
- HLIO 98.08
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.